Global Information
회사소개 | 문의 | 비교리스트

세계의 화학요법 유발성 빈혈 치료제 시장 조사 리포트 : 유형, 용도, 지역별 예측(-2027년) - COVID-19의 누적 영향

Chemotherapy Induced Anemia Drug Market Research Report by Type, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

리서치사 360iResearch LLP
발행일 2022년 07월 상품코드 1104218
페이지 정보 영문 246 Pages 배송안내 1-2일 (영업일 기준)
가격
US $ 3,949 ₩ 5,175,000 Online Access - 1 Year (Single User License)
US $ 4,949 ₩ 6,485,000 PDF, Excel & Online Access - 1 Year (Single User License)
US $ 5,949 ₩ 7,796,000 PDF, Excel & Online Access - 1 Year (Up to 5 User License)
US $ 7,949 ₩ 10,417,000 PDF, Excel & Online Access - 1 Year (Site License)
US $ 9,949 ₩ 13,038,000 PDF, Excel & Online Access - 1 Year (Enterprise User License)


세계의 화학요법 유발성 빈혈 치료제 시장 조사 리포트 : 유형, 용도, 지역별 예측(-2027년) - COVID-19의 누적 영향 Chemotherapy Induced Anemia Drug Market Research Report by Type, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
발행일 : 2022년 07월 페이지 정보 : 영문 246 Pages

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

화학요법 유발성 빈혈 치료제 세계 시장 규모는 2021년에 7억 2347만 달러, 2022년에는 7억 9241만 달러에 이를 것으로 추정되며, 2027년 12억 6,671만 달러에 이를 때까지 연평균 복합 성장률(CAGR) 9.78%로 성장할 것으로 예측됩니다.

시장 통계

본 보고서에서는 달러, 유로, 엔, 파운드, 호주 달러, 캐나다 달러, 스위스 프랑의 주요 7개 통화 시장 규모 및 예측 정보를 제공하고 있습니다. 환율 데이터를 쉽게 이용할 수 있기 때문에 조직 리더가 더 나은 의사결정을 내릴 수 있도록 지원합니다. 본 보고서에서는 2019년과 2020년을 과거년도, 2021년을 기본년도, 2022년을 추정년도, 2023년부터 2027년까지를 예측 기간으로 간주하고 있습니다.

Competitive Strategic Window

Competitive Strategic Window는 시장, 용도, 지역 경쟁 상황을 분석하고 벤더의 능력과 향후 성장 기회의 정합성 또는 적합성을 정의하는 데에 도움이 됩니다. 또한 벤더가 예측 기간에 새로운 사업 확대와 성장을 이루기 위해서 M&A 전략, 지역 확대, 연구개발, 신제품 도입 전략을 채택할 때의 최적 또는 유리한 적합성을 설명했습니다.

FPNV 포지셔닝 매트릭스

FPNV 포지셔닝 매트릭스에서는 화학요법 유발성 빈혈 치료제 시장 벤더를 사업 전략(사업 성장, 산업 범위, 재무 목표 유용성), 제품 만족도에 근거하여 평가/분류했습니다. 이 리포트에서는 화학요법 유발성 빈혈 치료제 시장 벤더를 사업 전략(사업 성장, 산업 범위, 재무 목표 시행 힘, 채널 지원) 및 제품 만족도(비용 퍼포먼스, 편리한 사용, 제품 기능, 고객 상황)에 근거하여 평가하고, 기업 의사결정과 경쟁 구도 파악에 유용하게 이용할 수 있습니다.

시장 점유율 분석

시장 점유율 분석에서는 시장 전체에 대한 기여도를 고려한 벤더 분석을 제공합니다. 같은 분야의 타 벤더와 비교하여 시장 전체에 대한 매출 기여도를 파악할 수 있습니다. 벤더가 기타 벤더와 비교할 때 매출 창출이나 고객 기반 면에서 어떠한 퍼포먼스를 발휘하고 있는지에 대한 인사이트를 제공합니다. 시장 점유율을 파악하여 기준년도의 벤더 규모나 경쟁력을 알 수 있습니다. 축적, 단편화, 우위성, 합병 특징으로부터 시장의 특징을 파악할 수 있습니다.

본 보고서는 다음 포인트에 관한 인사이트를 제공합니다.

  • 시장 침투도 : 주요 기업이 제공하는 시장에 관한 정보를 제공합니다.
  • 시장 개척 : 유리한 신흥 시장에 관한 상세 정보를 제공하고, 시장 성숙 부문의 침투도를 분석합니다.
  • 시장 다양화 : 신제품 출시, 미개척 지역, 최근 개발, 투자에 관한 상세한 정보를 제공합니다.
  • 경쟁 평가와 정보 : 주요 기업의 시장 점유율, 전략, 제품, 인증, 규제 상황, 특허 상황, 제조능력에 관한 철저한 평가를 제공합니다.
  • 제품 개발 및 혁신 : 향후 기술, R&D 활동, 획기적인 제품 개발에 관한 인사이트를 제공합니다.

본 보고서는 다음 질문에 대한 답변이 될 것입니다.

  • 화학요법 유발성 빈혈 치료제 세계 시장 규모 및 예측은?
  • 예측 기간에 화학요법 유발성 빈혈 치료제 세계 시장을 형성하는 성장 저해요인이나 COVID-19의 영향은?
  • 화학요법 유발성 빈혈 치료제 세계 시장에서 예측 기간에 투자해야 할 제품/부문/용도/영역은 무엇인가?
  • 화학요법 유발성 빈혈 치료제 세계 시장의 Competitive Strategic Window는?
  • 화학요법 유발성 빈혈 치료제 세계 시장의 기술 동향과 규제 프레임워크는?
  • 화학요법 유발성 빈혈 치료제 세계 시장 주요 벤더의 시장 점유율은?
  • 화학요법 유발성 빈혈 치료제 세계 시장 진출에 적절한 방식과 전략적 수단은?

목차

제1장 서문

  • 조사 목적
  • 시장 세분화와 조사 범위
  • 조사 대상년도
  • 통화 및 가격
  • 언어
  • 제한 사항
  • 전제조건
  • 이해관계자

제2장 조사 방법

  • 정의 : 조사 목적
  • 결정 : 조사 설계
  • 준비 : 조사표 작성
  • 수집 : 데이터 소스
  • 분석 : 데이터 분석
  • 정식화 : 데이터 검증
  • 출판 : 조사 보고서 작성
  • 반복 : 보고서 업데이트

제3장 개요

제4장 시장 개요

제5장 시장 인사이트

  • 시장 역학
    • 성장 촉진요인
    • 성장 저해요인
    • 비즈니스 기회
    • 과제
  • COVID-19의 누적 영향

제6장 화학요법 유발성 빈혈 치료제 시장 : 유형별

  • Epoetin Zeta Biosimilar
  • Ferric Carboxymaltose
  • Pegylated Erythropoietin

제7장 화학요법 유발성 빈혈 치료제 시장, 용도별

  • 클리닉
  • 재택치료
  • 병원

제8장 아메리카 화학요법 유발성 빈혈 치료제 시장

  • 아르헨티나
  • 브라질
  • 캐나다
  • 멕시코
  • 미국

제9장 아시아태평양 화학요법 유발성 빈혈 치료제 시장

  • 호주
  • 중국
  • 인도
  • 인도네시아
  • 일본
  • 말레이시아
  • 필리핀
  • 싱가포르
  • 한국
  • 대만
  • 태국

제10장 유럽, 중동 및 아프리카 화학요법 유발성 빈혈 치료제 시장

  • 프랑스
  • 독일
  • 이탈리아
  • 네덜란드
  • 카타르
  • 러시아
  • 사우디아라비아
  • 남아프리카공화국
  • 스페인
  • 아랍에미리트(UAE)
  • 영국

제11장 경쟁 구도

  • FPNV 포지셔닝 매트릭스
    • 쿼드런트
    • 사업 전략
    • 제품 만족도
  • 시장 순위 분석
  • 주요 기업별 시장 점유율 분석
  • 경쟁 시나리오
    • 인수합병(M&A)
    • 계약/협업/파트너십
    • 신제품 출시 및 개선
    • 투자 및 펀딩
    • 수상/표창/확대

제12장 기업 개요

  • 3SBio Inc.
  • BIOCAD
  • Chong Kun Dang Pharmaceutical Corp.
  • Dr. Reddy's Laboratories Limited
  • Galenica Ltd.
  • Johnson & Johnson
  • Panacea Biotec Limited
  • Pfizer Inc.
  • PharmaEssentia Corporation
  • PhytoHealth Corporation
  • Pieris Pharmaceuticals Inc
  • Sandoz International GmbH
  • SBI Pharmaceuticals Co., Ltd.
  • Therapure Biopharma Inc.
  • Tolero Pharmaceuticals, Inc.

제13장 부록

  • 디스커션 가이드
  • 라이선스와 가격에 대해
LSH 22.08.02

LIST OF FIGURES

  • FIGURE 1. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2021 VS 2027 (USD MILLION)
  • FIGURE 3. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 4. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY REGION, 2021 VS 2027 (%)
  • FIGURE 5. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY REGION, 2027
  • FIGURE 7. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET DYNAMICS
  • FIGURE 8. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
  • FIGURE 9. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY TYPE, 2021 VS 2027 (USD MILLION)
  • FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY TYPE, 2027
  • FIGURE 11. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY EPOETIN ZETA BIOSIMILAR, 2019-2027 (USD MILLION)
  • FIGURE 12. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY EPOETIN ZETA BIOSIMILAR, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 13. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY FERRIC CARBOXYMALTOSE, 2019-2027 (USD MILLION)
  • FIGURE 14. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY FERRIC CARBOXYMALTOSE, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 15. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY PEGYLATED ERYTHROPOIETIN, 2019-2027 (USD MILLION)
  • FIGURE 16. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY PEGYLATED ERYTHROPOIETIN, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 17. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
  • FIGURE 18. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
  • FIGURE 19. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY APPLICATION, 2027
  • FIGURE 20. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY CLINIC, 2019-2027 (USD MILLION)
  • FIGURE 21. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY CLINIC, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 22. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY HOMECARE, 2019-2027 (USD MILLION)
  • FIGURE 23. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY HOMECARE, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 24. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY HOSPITAL, 2019-2027 (USD MILLION)
  • FIGURE 25. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY HOSPITAL, BY REGION, 2021 VS 2027 (USD MILLION)
  • FIGURE 26. AMERICAS CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 27. AMERICAS CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
  • FIGURE 28. AMERICAS CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
  • FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY COUNTRY, 2027
  • FIGURE 30. ARGENTINA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 31. BRAZIL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 32. CANADA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 33. MEXICO CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 34. UNITED STATES CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 35. UNITED STATES CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY STATE, 2021 VS 2027 (%)
  • FIGURE 36. UNITED STATES CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
  • FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY STATE, 2027
  • FIGURE 38. ASIA-PACIFIC CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 39. ASIA-PACIFIC CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
  • FIGURE 40. ASIA-PACIFIC CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
  • FIGURE 41. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY COUNTRY, 2027
  • FIGURE 42. AUSTRALIA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 43. CHINA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 44. INDIA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 45. INDONESIA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 46. JAPAN CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 47. MALAYSIA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 48. PHILIPPINES CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 49. SINGAPORE CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 50. SOUTH KOREA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 51. TAIWAN CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 52. THAILAND CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 53. EUROPE, MIDDLE EAST & AFRICA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 54. EUROPE, MIDDLE EAST & AFRICA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
  • FIGURE 55. EUROPE, MIDDLE EAST & AFRICA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
  • FIGURE 56. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY COUNTRY, 2027
  • FIGURE 57. FRANCE CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 58. GERMANY CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 59. ITALY CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 60. NETHERLANDS CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 61. QATAR CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 62. RUSSIA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 63. SAUDI ARABIA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 64. SOUTH AFRICA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 65. SPAIN CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 66. UNITED ARAB EMIRATES CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 67. UNITED KINGDOM CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • FIGURE 68. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET: FPNV POSITIONING MATRIX, 2021
  • FIGURE 69. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SHARE, BY KEY PLAYER, 2021
  • FIGURE 70. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 4. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 5. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 6. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY EPOETIN ZETA BIOSIMILAR, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 7. AMERICAS CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY EPOETIN ZETA BIOSIMILAR, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 8. UNITED STATES CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY EPOETIN ZETA BIOSIMILAR, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 9. ASIA-PACIFIC CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY EPOETIN ZETA BIOSIMILAR, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 10. EUROPE, MIDDLE EAST & AFRICA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY EPOETIN ZETA BIOSIMILAR, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 11. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY FERRIC CARBOXYMALTOSE, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 12. AMERICAS CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY FERRIC CARBOXYMALTOSE, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 13. UNITED STATES CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY FERRIC CARBOXYMALTOSE, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 14. ASIA-PACIFIC CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY FERRIC CARBOXYMALTOSE, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 15. EUROPE, MIDDLE EAST & AFRICA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY FERRIC CARBOXYMALTOSE, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 16. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY PEGYLATED ERYTHROPOIETIN, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 17. AMERICAS CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY PEGYLATED ERYTHROPOIETIN, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 18. UNITED STATES CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY PEGYLATED ERYTHROPOIETIN, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 19. ASIA-PACIFIC CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY PEGYLATED ERYTHROPOIETIN, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 20. EUROPE, MIDDLE EAST & AFRICA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY PEGYLATED ERYTHROPOIETIN, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 21. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 22. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY CLINIC, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 23. AMERICAS CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY CLINIC, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 24. UNITED STATES CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY CLINIC, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 25. ASIA-PACIFIC CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY CLINIC, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 26. EUROPE, MIDDLE EAST & AFRICA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY CLINIC, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 27. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY HOMECARE, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 28. AMERICAS CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY HOMECARE, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 29. UNITED STATES CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY HOMECARE, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY HOMECARE, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 31. EUROPE, MIDDLE EAST & AFRICA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY HOMECARE, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 32. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY HOSPITAL, BY REGION, 2019-2027 (USD MILLION)
  • TABLE 33. AMERICAS CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 34. UNITED STATES CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY HOSPITAL, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 36. EUROPE, MIDDLE EAST & AFRICA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 37. AMERICAS CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 38. AMERICAS CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 39. AMERICAS CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 40. AMERICAS CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 41. ARGENTINA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 42. ARGENTINA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 43. ARGENTINA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 44. BRAZIL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 45. BRAZIL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 46. BRAZIL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 47. CANADA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 48. CANADA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 49. CANADA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 50. MEXICO CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 51. MEXICO CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 52. MEXICO CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 53. UNITED STATES CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 54. UNITED STATES CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
  • TABLE 55. UNITED STATES CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 56. UNITED STATES CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 61. AUSTRALIA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 62. AUSTRALIA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 63. AUSTRALIA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 64. CHINA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 65. CHINA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 66. CHINA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 67. INDIA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 68. INDIA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 69. INDIA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 70. INDONESIA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 71. INDONESIA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 72. INDONESIA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 73. JAPAN CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 74. JAPAN CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 75. JAPAN CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 76. MALAYSIA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 77. MALAYSIA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 78. MALAYSIA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 79. PHILIPPINES CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 80. PHILIPPINES CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 81. PHILIPPINES CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 82. SINGAPORE CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 83. SINGAPORE CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 84. SINGAPORE CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 85. SOUTH KOREA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 86. SOUTH KOREA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 87. SOUTH KOREA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 88. TAIWAN CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 89. TAIWAN CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 90. TAIWAN CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 91. THAILAND CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 92. THAILAND CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 93. THAILAND CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 98. FRANCE CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 99. FRANCE CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 100. FRANCE CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 101. GERMANY CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 102. GERMANY CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 103. GERMANY CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 104. ITALY CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 105. ITALY CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 106. ITALY CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 107. NETHERLANDS CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 108. NETHERLANDS CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 109. NETHERLANDS CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 110. QATAR CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 111. QATAR CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 112. QATAR CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 113. RUSSIA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 114. RUSSIA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 115. RUSSIA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 116. SAUDI ARABIA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 117. SAUDI ARABIA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 118. SAUDI ARABIA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 119. SOUTH AFRICA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 120. SOUTH AFRICA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 121. SOUTH AFRICA CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 122. SPAIN CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 123. SPAIN CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 124. SPAIN CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 125. UNITED ARAB EMIRATES CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 126. UNITED ARAB EMIRATES CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 127. UNITED ARAB EMIRATES CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 128. UNITED KINGDOM CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, 2019-2027 (USD MILLION)
  • TABLE 129. UNITED KINGDOM CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
  • TABLE 130. UNITED KINGDOM CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
  • TABLE 131. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
  • TABLE 132. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
  • TABLE 133. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
  • TABLE 134. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET RANKING
  • TABLE 135. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET SHARE, BY KEY PLAYER, 2021
  • TABLE 136. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET MERGER & ACQUISITION
  • TABLE 137. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 138. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 139. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET INVESTMENT & FUNDING
  • TABLE 140. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET AWARD, RECOGNITION, & EXPANSION
  • TABLE 141. GLOBAL CHEMOTHERAPY INDUCED ANEMIA DRUG MARKET: LICENSE & PRICING

The Global Chemotherapy Induced Anemia Drug Market size was estimated at USD 723.47 million in 2021 and expected to reach USD 792.41 million in 2022, and is projected to grow at a CAGR 9.78% to reach USD 1,266.71 million by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Chemotherapy Induced Anemia Drug to forecast the revenues and analyze the trends in each of the following sub-markets:

  • Based on Type, the market was studied across Epoetin Zeta Biosimilar, Ferric Carboxymaltose, and Pegylated Erythropoietin.
  • Based on Application, the market was studied across Clinic, Homecare, and Hospital.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Chemotherapy Induced Anemia Drug market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Chemotherapy Induced Anemia Drug Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Chemotherapy Induced Anemia Drug Market, including 3SBio Inc., BIOCAD, Chong Kun Dang Pharmaceutical Corp., Dr. Reddy's Laboratories Limited, Galenica Ltd., Johnson & Johnson, Panacea Biotec Limited, Pfizer Inc., PharmaEssentia Corporation, PhytoHealth Corporation, Pieris Pharmaceuticals Inc, Sandoz International GmbH, SBI Pharmaceuticals Co., Ltd., Therapure Biopharma Inc., and Tolero Pharmaceuticals, Inc..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Chemotherapy Induced Anemia Drug Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Chemotherapy Induced Anemia Drug Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Chemotherapy Induced Anemia Drug Market?
  • 4. What is the competitive strategic window for opportunities in the Global Chemotherapy Induced Anemia Drug Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Chemotherapy Induced Anemia Drug Market?
  • 6. What is the market share of the leading vendors in the Global Chemotherapy Induced Anemia Drug Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Chemotherapy Induced Anemia Drug Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Potential demand attributed to rising prevalence of anemia and chronic diseases across the globe
      • 5.1.1.2. Proliferation in chemotherapy procedures coupled with increasing healthcare expenses over chronic disease treatments
      • 5.1.1.3. Favorable governmental initiatives in development of healthcare infrastructures with innovation of chemotherapy induced anemia drugs
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with drug manufacturing and drug development across the globe
    • 5.1.3. Opportunities
      • 5.1.3.1. Emergence of advanced drug solutions associated with chemotherapy induced anemia treatment
      • 5.1.3.2. Strategic collaborations and significant investments to enhance the research and development for drug developments
    • 5.1.4. Challenges
      • 5.1.4.1. Concern regarding side effects and treatment impacts of chemotherapy induced anemia drugs
  • 5.2. Cumulative Impact of COVID-19

6. Chemotherapy Induced Anemia Drug Market, by Type

  • 6.1. Introduction
  • 6.2. Epoetin Zeta Biosimilar
  • 6.3. Ferric Carboxymaltose
  • 6.4. Pegylated Erythropoietin

7. Chemotherapy Induced Anemia Drug Market, by Application

  • 7.1. Introduction
  • 7.2. Clinic
  • 7.3. Homecare
  • 7.4. Hospital

8. Americas Chemotherapy Induced Anemia Drug Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Chemotherapy Induced Anemia Drug Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand

10. Europe, Middle East & Africa Chemotherapy Induced Anemia Drug Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis, By Key Player
  • 11.4. Competitive Scenario
    • 11.4.1. Merger & Acquisition
    • 11.4.2. Agreement, Collaboration, & Partnership
    • 11.4.3. New Product Launch & Enhancement
    • 11.4.4. Investment & Funding
    • 11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. 3SBio Inc.
  • 12.2. BIOCAD
  • 12.3. Chong Kun Dang Pharmaceutical Corp.
  • 12.4. Dr. Reddy's Laboratories Limited
  • 12.5. Galenica Ltd.
  • 12.6. Johnson & Johnson
  • 12.7. Panacea Biotec Limited
  • 12.8. Pfizer Inc.
  • 12.9. PharmaEssentia Corporation
  • 12.10. PhytoHealth Corporation
  • 12.11. Pieris Pharmaceuticals Inc
  • 12.12. Sandoz International GmbH
  • 12.13. SBI Pharmaceuticals Co., Ltd.
  • 12.14. Therapure Biopharma Inc.
  • 12.15. Tolero Pharmaceuticals, Inc.

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing
Back to Top
전화 문의
F A Q